Best peptides for muscle recovery
Peptides researched for injury healing, tissue repair, and exercise recovery.
Peptides for muscle recovery are among the most discussed in fitness and biohacking communities. While some show genuine promise in animal research, it is important to understand that most lack human clinical trials. Here is what the evidence says.
One of the most researched peptides in cosmetic science. Naturally occurring in human plasma, GHK-Cu declines with age and is involved in wound healing, collagen synthesis, and potentially hair growth.
What evidence supports
- ✓promotes wound healing and tissue repair in multiple studies
- ✓stimulates collagen and glycosaminoglycan synthesis
- ✓may support hair follicle health and growth in some studies
Key concern: can cause a purging-like skin response initially
The most mainstream peptide supplement. Collagen broken down into small, absorbable peptides for oral use. Widely studied for skin, joint, and general connective tissue support.
What evidence supports
- ✓multiple randomized controlled trials show modest improvement in skin elasticity and hydration at 2.5–10g/day over 8+ weeks
- ✓some evidence supports improved joint comfort with consistent supplementation
- ✓bioavailability of hydrolyzed form is significantly better than whole collagen protein
Key concern: results are modest and gradual, not dramatic or immediate
Available in
A truncated analog of growth hormone-releasing hormone (GHRH) that was FDA-approved for diagnosing and treating growth hormone deficiency in children. It stimulates the pituitary to produce GH naturally, making it one of the most commonly prescribed peptides in anti-aging and hormone optimization clinics.
What evidence supports
- ✓stimulates endogenous GH release in a dose-dependent manner
- ✓was FDA-approved (as Geref) for GH deficiency diagnosis and pediatric treatment
- ✓clinical studies show increased IGF-1 levels and improved body composition in GH-deficient patients
Key concern: Geref was voluntarily withdrawn from market in 2008 for commercial (not safety) reasons
One of the earliest synthetic growth hormone secretagogues, GHRP-6 stimulates potent GH release through the ghrelin receptor. It is known for causing intense hunger and has been widely used in research and the bodybuilding community, though it was never approved for clinical use.
What evidence supports
- ✓potent dose-dependent GH release demonstrated across multiple studies
- ✓increases IGF-1 levels
- ✓stimulates appetite significantly via ghrelin pathway activation
Key concern: intense hunger is the most commonly reported side effect
A synthetic 15-amino acid peptide derived from a larger protein found in human gastric juice. BPC-157 is one of the most widely used research peptides in the recovery and biohacking community for musculoskeletal healing and gut repair. The preclinical evidence across tissue types is remarkably consistent — and unusually broad — but human clinical trial data remains limited relative to its popularity.
What evidence supports
- ✓robust animal model evidence for accelerated healing of tendons, ligaments, muscle, gut mucosa, bone, and cornea
- ✓Phase 2 human trial for ulcerative colitis showed statistically significant dose-dependent improvement in endoscopic and clinical scores
- ✓small human studies show reduced musculoskeletal pain after injection
Key concern: no completed large-scale human safety trials — preclinical safety data is reassuring but not a substitute
Available in
TB-500 is a synthetic 7-amino acid acetylated peptide fragment (Ac-LKKTETQ) corresponding to residues 17–23 of thymosin beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in virtually every mammalian cell. TB-500 retains the principal actin-binding domain of the parent molecule. It is the most frequently combined stack partner with BPC-157 in the research peptide community, with the two compounds thought to act through complementary mechanisms — BPC-157 providing local angiogenic and anti-inflammatory signalling, TB-500 driving systemic cell migration toward injury sites. The evidence distinction between TB-500 and full-length Thymosin Beta-4 is critical: the human clinical trial data uses the full-length compound, not the fragment.
What evidence supports
- ✓robust animal model evidence for accelerated healing of cardiac, tendon, ligament, muscle, corneal, dermal, and neural tissue
- ✓preclinical cardiac evidence base is the strongest of any research peptide — post-MI remodelling models consistently show improved cardiac function with Tβ4 administration
- ✓2025 cardiac RCT and Phase II/III ophthalmic trials showed positive results — but these used full-length Tβ4, not the TB-500 fragment; results cannot be directly applied to TB-500
Key concern: no completed human safety or efficacy trials for TB-500 specifically
A potent synthetic hexapeptide that stimulates growth hormone release from the pituitary — more potent than GHRP-6 on a per-dose basis but with a greater propensity to elevate cortisol and prolactin. Used experimentally for GH stimulation and cardiac protection research.
What evidence supports
- ✓produces robust GH pulses in small human studies at 1–2 mcg/kg
- ✓Ghigo et al. (1994) showed GH, IGF-1, cortisol, and prolactin elevation
- ✓cardiac protection in ischemia-reperfusion animal models
Key concern: elevates cortisol and prolactin more than Ipamorelin — meaningful drawback for regular use
The full 43-amino acid thymic peptide from which TB-500 is derived. TB-500 is only the active fragment (amino acids 17–23: LKKTET). TB-4 itself has broader biological activity including actin sequestration, anti-inflammatory effects, and tissue repair — though most consumer products labeled TB-4 actually contain the shorter TB-500 fragment.
What evidence supports
- ✓regulates actin dynamics through G-actin sequestration in multiple in vitro and animal models
- ✓promotes wound healing and corneal repair in animal studies
- ✓Phase 2 clinical trial (RegeneRx) for dry eye syndrome showed modest efficacy
Key concern: no approved human use anywhere — research chemical only
Mechano Growth Factor (MGF) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical strain (exercise). It activates satellite cells to repair and grow muscle. The pegylated form (PEG-MGF) has a longer half-life. Used experimentally in fitness contexts but human evidence is essentially absent.
What evidence supports
- ✓MGF splice variant confirmed produced in human skeletal muscle in response to exercise (biopsy studies)
- ✓activates satellite cell proliferation in vitro
- ✓animal studies show increased muscle cross-sectional area with exogenous MGF
Key concern: no human clinical trials demonstrating efficacy or safety
A 344-amino acid isoform of follistatin, a naturally occurring glycoprotein that binds and neutralizes myostatin — the protein that limits muscle mass. By inhibiting myostatin, follistatin theoretically removes the body's built-in ceiling on muscle growth. Popularized following myostatin knock-out animal studies, but human evidence for exogenous peptide administration is negligible.
What evidence supports
- ✓gene therapy delivery to macaques produced significant muscle hypertrophy without toxicity (Nationwide Children's Hospital, 2009)
- ✓pilot gene therapy trial in Becker muscular dystrophy (6 patients) showed modest muscle function improvements
- ✓myostatin inhibition consistently produces hypertrophy across multiple animal species
Key concern: virtually no human evidence for exogenous peptide administration — the gene therapy data involves completely different delivery
Not sure which is right for you?
Take our quiz for a personalized recommendation based on your goals and preferences.
Take the Peptide QuizMedical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.